BLOG

FDA Proposed Rules: Pharma Solutions’ Comment Submission

FDA Proposed Rules: Pharma Solutions’ Comment Submission

FDA Proposed Rules: Pharma Solutions' Comment Submission Written-by: Sumeet Singh, CEO Preemption Section 585(b): The Proposed Rules suggest that Preemption shall go beyond license requirements and cover standards for Standard Operating Procedures, disciplinary...

read more

Recent Articles

NABP DDA: New Process & “Ineligibility Matrix”

Letter from the CEO on 2022

Letter from the CEO on 2022 Dear all, This time of year always brings a sense reflection – to understand the ups and downs of the year prior, and to...

read more
NABP DDA: New Process & “Ineligibility Matrix”

NCDQS 2021 Recap

NCDQS 2021 Recap NCDQS has experienced extensive success in 2021, as industry and state regulating bodies recognize the value of transparency and...

read more
NABP DDA: New Process & “Ineligibility Matrix”

Top SOM Insights from 2021

Top SOM Insights from 2021 The continuous development and sophistication of NavigateSOM, along with helping clients meet their objectives, pushes...

read more

Email Newsletter